Role of Surgery in Treatment of Recurrent Brian Glioma:Prognostic Factors and Outcome
NCT ID: NCT04562077
Last Updated: 2020-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
25 participants
OBSERVATIONAL
2020-10-31
2021-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
For more diffuse invasive gliomas (Grade II or higher), initial management typically includes maximal safe resection when possible.
Increasing evidence supports an association between extent of resection and prolonged progression-free and overall survival for patients with diffuse gliomas of all types and grades Many studies reported that more that 90%of patients with glioma showed recurrence at the orginal tumor location.
Review the outcomes of re-operation in treatment of recurrent brain gliomas To determine the prognostic factors which can predict which patient would benefit from multiple surgery .
Trail to Improve the outcome of these patients and decrease rate of complications
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Impact of Surgical Resection Extent for Supratentorial High Grade Gliomas.
NCT03997136
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
NCT06146725
Surgical Management of Low Grade Glioma
NCT06499922
Supratotal Resection for Gliomas Within Noneloquent Areas
NCT02676687
Impact of iMRI on the Extent of Resection in Patients With Newly Diagnosed Glioblastomas
NCT02379572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Patients who will undergo re-operation for treatment of a recurrent brain glioma at the time of study(one year) Histological types : Different histological types of glioma.
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamad Sayed Mohamad
assistant lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed AlGhriany, phD
Role: STUDY_DIRECTOR
professor of neurosurgery assiut university
Ahmed AlShanawany, phD
Role: STUDY_DIRECTOR
assistant professor of neurosurgery assiut university
Mohamad S Waer
Role: PRINCIPAL_INVESTIGATOR
Resident at department of neurosurgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assuit University Hospitals
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
surgery in glioma
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.